GILBERTSON RYAN RANDALL 4
4 · Sun BioPharma, Inc. · Filed Jan 24, 2019
Insider Transaction Report
Form 4
GILBERTSON RYAN RANDALL
10% Owner
Transactions
- Sale
Warrants (right to buy)
2018-08-15−47,025→ 0 total(indirect: Northern Capital Partners I, LP)Exercise: $5.00From: 2018-05-16Exp: 2021-05-16→ Common Stock (47,025 underlying) - Sale
Common Stock
2018-08-15−47,025→ 0 total(indirect: Northern Capital Partners I, LP)
Holdings
- 555,538
Common Stock
Footnotes (1)
- [F1]47,025 units, with each unit consisting of one share of common stock and a warrant to purchase an additional share of common stock, were sold by the reporting person for an aggregate price of $200,000.